{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif
CHEK-CO
Correlation between Hyperuricemia and Co-Morbidities in Indian Patients
  1. Type of practice *

  2. Prevalence of following mentioned comorbidities in your practice? *
    3. Percentage <20% 21-30% 31-40% >40%
    CKD

    Hypertension

    Diabetes

    Dyslipidemia

  3. How does incidence of following comorbidities vary as per gender? *
    4. Incidence More Commonly seen in Males More Commonly seen in Females
    CKD

    Hypertension

    Diabetes

    Dyslipidemia

  4. How does incidence of following comorbidities vary as per age group? *
    5. Age group <30 years 30-50 years 51-75 years >75 years
    CKD

    Hypertension

    Diabetes

    Dyslipidemia

  5. Percentage of patients with following comorbidities in your practice who have hyperuricemia? *
    6. Percentage <25% 25-50% 51-75% >75%
    CKD

    Hypertension

    Diabetes

    Dyslipidemia

  6. At what uric acid levels, do you treat your patients with following comorbidities for hyperuricemia? *
    7. Uric Acid level >6 mg/dl >7 mg/dl >8 mg/dl >9 mg>dl
    CKD

    Hypertension

    Diabetes

    Dyslipidemia

  7. Management regimen for hyperuricemia in patients with following comorbidities? *
    8. CKD
    Hypertension
    Diabetes
    Dyslipidemia
  8. Common Lifestyle modifications suggested by you to patients suffering from hyperuricemia associated with: *
    9. CKD
    Hypertension
    Diabetes
    Dyslipidemia
  9. Rank the drugs used to control hyperuricemia in patients with following comorbidities? *

    (1 – Excellent, 2 – Very Good, 3 – Good, 4 – Average)

    10. Drugs CKD Hypertension Diabetes Dyslipidemia
    Febuxostat
    Allopurinol
    Probenecid
    Colchicine
  10. What percentage of your patients with following comorbidities currently undergoing hyperuricemia treatment are on ? *
    11. Febuxostat Allopurinol Probenecid Colchicine
    CKD

    Febuxostat Allopurinol Probenecid Colchicine
    Hypertension

    Febuxostat Allopurinol Probenecid Colchicine
    Diabetes

    Febuxostat Allopurinol Probenecid Colchicine
    Dyslipidemia

  11. Dosage for hyperuricemia treatment in following patients: *
    12. Febuxostat
    (Dose in mg)    		 Allopurinol
    (Dose in mg)     		Probenecid
    (Dose in mg)     		Colchicine
    (Dose in mg)
    CKD

    Hypertension

    Diabetes

    Dyslipidemia

  12. Duration of treatment for hyperuricemia treatment in following patients: *
    13. Febuxostat
    (In weeks)    		 Allopurinol
    (In weeks)     		Probenecid
    (In weeks)     		Colchicine
    (In weeks)
    CKD

    Hypertension

    Diabetes

    Dyslipidemia

  13. Rank the safety profile for below mentioned ULTs as per your current observation ? *

    (1 – Excellent, 2 – Very Good, 3 – Good, 4 – Poor)

    14. Febuxostat
    Allopurinol
    Topiroxostat
    Probenecid
    Colchicine
  14. In following Comorbid patients with controlled uric acid levels, do you continue treatment? *
    15. Yes No
    CKD

    Hypertension

    Diabetes

    Dyslipidemia

  15. Patient’s adherence to your treatment regimen for Hyperuricemia in patients with following comorbidities would be ? *
    16. Percentage <50% 50-70% 71-90% >90%
    CKD

    Hypertension

    Diabetes

    Dyslipidemia

  16. In case of non-compliance, what are the key factors? *